BRIEF-Morgan Stanley reports 5.2 pct passive stake in Twilio
* Morgan Stanley reports 5.2 percent passive stake in Twilio Inc as of October 13 - SEC filing Source text: [http://bit.ly/2e8oOmU] Further company coverage:
July 2 Vivus Inc's largest shareholder First Manhattan Co said it proposed a former senior executive of AstraZeneca Plc as chief executive of the obesity drug maker, a move that could swing shareholder support for the activist investor's board slate ahead of a proxy vote.
Anthony Zook, who was executive vice-president for global commercial operations at AstraZeneca until February, helped in launch some of the British drug giant's biggest products, including the blockbuster heartburn drug Nexium and cholesterol medicine Crestor.
First Manhattan, owner of 9.9 percent of Vivus shares, has repeatedly criticized the drug maker for mishandling the launch of its obesity drug Qsymia.
First Manhattan put forth a slate of nine candidates that it hopes will win seats on the Vivus board at the shareholder meeting on July 15.
* Anson Funds Management LP reports 6.5 percent passive stake in Inventergy Global Inc as of October 11 - SEC filing Source text: [http://bit.ly/2eqvUXw] Further company coverage:
Oct 21 EQT on Friday closed its acquisition of Press Ganey Holdings Inc, a provider of patient satisfaction surveys, giving the Swedish buyout firm its first foothold in the U.S. healthcare market, the company said.